Zimbabwe has rejected a substantial American healthcare agreement worth $367m (272 million pounds) over five years due to Washington's demand for confidential information.
This move became public after a government memo dated December was leaked, revealing that President Emmerson Mnangagwa felt the agreement was "lopsided".
An official representative has since stated that the US was demanding access to genetic material for research and commercial purposes while was not willing to share the resulting advantages from any future medical innovations.
"We must now begin the difficult and regrettable task of scaling back our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the US had furnished more than $1.9bn as health assistance to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has appealed for continued talks to reach a deal acceptable to all parties so the nation's critical HIV programme can be sustained.
Broader Implications
This rejection follows a similar situation in Kenya, where a high court halted a similar health funding agreement after concerns were raised about the safety of Kenyans' health data.
After returning to the presidency last year, US President Donald Trump has slashed overseas assistance and closed the key foreign aid agency.
USAID had managed assistance for the American government, but Trump argued its spending was "inefficient" and his government was pursuing direct bilateral deals to enhance openness and accountability.
Based on statements, 16 African countries have so far agreed to these new agreements, constituting more than $18.3bn of fresh investment.
Specifics of the Declined Deal
This assistance for Zimbabwe would have funded "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this cooperation might have yielded immense advantages for Zimbabwean communities, especially the 1.2 million men, women and children presently receiving HIV treatment via American-funded programmes," the Ambassador commented.
However, government spokesperson Nick Mangwana said the arrangement was "unfair".
"The proposal required Zimbabwe to share its genetic material and health information over an extended period, with no corresponding promise of benefiting from any scientific breakthroughs – like new medicines or tests – that might result from that shared data," Mangwana explained.
"In essence, our nation would supply the raw materials for scientific discovery without any certainty that the resulting innovations would be available to our people should a future health crisis emerge."
Sovereignty and International Frameworks
Mangwana further said that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one deals were disrupting structures already set up through the global organization.
Mangwana cited its Pathogen Access and Benefit Sharing scheme designed to deal with future global health emergencies.
"This system is designed to ensure that when a nation provides its data, the benefits – including vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the funds to create them."
These objections over the US deal "must not be interpreted as opposition to America," he added.
"We encourage further discussions with our American counterparts on how future collaboration might be arranged in a manner that honours the independence and dignity of both nations."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) said it acknowledged the government's concerns, but suggested that talks should continue since much of the nation's Aids initiatives relied on international support.
"In cases where specific concerns arise, including those relating to data governance or implementation frameworks, these can frequently be resolved via technical clarification and negotiated safeguards," the group said.
The situation underscores the ongoing tensions between receiving much-needed foreign assistance and safeguarding a country's data in an increasingly data-driven world.